Though Systolic BP Seems More Important, Diastolic BP Should Not Be Disregarded

Systolic hypertension is more often associated to cardiovascular events. However, diastolic blood pressure should not be disregarded, since it can also predict even worse outcomes.

Oportunidades perdidas en pacientes con enfermedad vascular periférica

Although systolic blood pressure is very frequently associated to adverse cardiovascular events, by no means should diastolic blood pressure be considered unimportant.

Such is the message of this study recently published in NEJM including data from more than 1.3 million outpatients, which shows that both systolic and diastolic hypertension are independently associated to cardiovascular events in the long run (acute myocardial infarction, ischemic or hemorrhagic stroke) regardless the type of blood pressure we might be focusing on.

Diastolic pressure should not be ignored, and we should focus on both BP goals (systolic and diastolic) for both hypertension diagnosis and treatment, to maximize the chances of therapy and effectively reduce population risk. According to the study authors, the AHA/ACC goals are reasonable and well founded, which is why they suggest aggressive treatment, especially when it comes to higher risk patients.


Read also: Dietary Supplements and Diets Show No Impact on Cardiovascular Risk.


They believe the J shaped curve should be of no concern.

The analysis included 36.8 million registries on blood pressure automatically measured. Using 140/90 as threshold, 18.9% presented hypertension, but when using 130/80 the incidence increased to 43.5%!!!

Regardless the BP definition we might choose, both systolic and diastolic pressure are independently associated to adverse events at 8 year follow up.

The correlation was stronger for systolic blood pressure.


Read also: Supervised Exercise and Revascularization for Intermittent Claudication.


The authors also explored the J shape curve previously observed between diastolic BP and events. This non-adjusted analysis showed increased risk both for peak and valley thresholds, but when adjusting by age, race and other comorbidities, the risk at the bottom of the curve disappeared.

According to this study, the J shape in this population (mostly healthy, mean age 53) is not a problem, so we should be more aggressive in trying to reach the proposed goals with no regard of the J curve, since after adjusting for variables, the risk in the lowest quartile disappears.

Título original: Effect of systolic and diastolic blood pressure on cardiovascular outcomes.

Referencia: Flint AC et al. N Engl J Med. 2019;381:243-251.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...